Home / News & Events
Research Highlight
Cutting-edge research goes beyond skin deep
Finding that the skin of people with scleroderma makes a unique sugar, GlycoNet researcher Lisa Willis is developing a way to better identify those at high risk of disease progression.
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
More stories
- All
- Awards
- Community
- Network Profile
- Press Release
- Research Highlight
The secret to healthy aging
It’s all about monitoring sugar – but not in the way you may think
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
Carbohydrate research in animal health supports Canadian economy
GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.
BioLab Business Magazine profile: GlycoNet facilitating glycomics research collaboration and innovation
A network serving the field of glycomics research provides a platform for connections and funding
A new research chair for dementia-causing diseases in children
Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.
GlycoNet and Partners Invest $6.5 Million in Carbohydrate Research with One Health Focus
This investment will support state-of-the-art glycomics research that focuses on different aspects of One Health—human, animal and environmental health.
GlycoNet welcomes three new members to the Board of Directors
Janice Bailey, Jason Acker and Louise St-Onge have joined the GlycoNet Board of Directors
Canadian Glycomics Network
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tel: 780-492-6204
Fax: 780-492-4147
Subscribe to GlycoNet’s Newsletter
© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.
English 
French